ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 114 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $23,331,000 | +9.2% | 3,869,063 | -34.8% | 0.01% | 0.0% |
| Q3 2019 | $21,361,000 | +43.0% | 5,933,833 | +6.4% | 0.01% | +33.3% |
| Q2 2019 | $14,942,000 | +34.6% | 5,575,528 | +48.6% | 0.01% | +20.0% |
| Q1 2019 | $11,103,000 | +406.5% | 3,750,994 | +172.1% | 0.01% | +400.0% |
| Q4 2018 | $2,192,000 | +802.1% | 1,378,567 | +1985.6% | 0.00% | – |
| Q3 2018 | $243,000 | +164.1% | 66,100 | +103.6% | 0.00% | – |
| Q2 2018 | $92,000 | -91.9% | 32,460 | -89.4% | 0.00% | – |
| Q1 2018 | $1,132,000 | +304.3% | 305,137 | +213.6% | 0.00% | – |
| Q4 2017 | $280,000 | -51.7% | 97,313 | -24.6% | 0.00% | – |
| Q3 2017 | $580,000 | +48.3% | 129,114 | +51.7% | 0.00% | – |
| Q2 2017 | $391,000 | -6.7% | 85,108 | -14.4% | 0.00% | – |
| Q1 2017 | $419,000 | -48.0% | 99,417 | -49.0% | 0.00% | – |
| Q4 2016 | $806,000 | -34.8% | 195,017 | +27.7% | 0.00% | -100.0% |
| Q3 2016 | $1,237,000 | -18.0% | 152,670 | -21.0% | 0.00% | 0.0% |
| Q2 2016 | $1,508,000 | +6.6% | 193,371 | +5.5% | 0.00% | 0.0% |
| Q1 2016 | $1,415,000 | -70.1% | 183,262 | -58.2% | 0.00% | -66.7% |
| Q4 2015 | $4,731,000 | +180.8% | 438,337 | +79.7% | 0.00% | +200.0% |
| Q3 2015 | $1,685,000 | -28.1% | 243,927 | -7.8% | 0.00% | 0.0% |
| Q2 2015 | $2,345,000 | -1.1% | 264,546 | +10.1% | 0.00% | -50.0% |
| Q1 2015 | $2,370,000 | -45.3% | 240,329 | -32.0% | 0.00% | 0.0% |
| Q4 2014 | $4,333,000 | – | 353,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |